These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22100887)

  • 1. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard.
    Wood JM; Major D; Heath A; Newman RW; Höschler K; Stephenson I; Clark T; Katz JM; Zambon MC
    Vaccine; 2012 Jan; 30(2):210-7. PubMed ID: 22100887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.
    Wagner R; Göpfert C; Hammann J; Neumann B; Wood J; Newman R; Wallis C; Alex N; Pfleiderer M
    Vaccine; 2012 Jun; 30(27):4113-22. PubMed ID: 22446639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
    Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study.
    Stephenson I; Das RG; Wood JM; Katz JM
    Vaccine; 2007 May; 25(20):4056-63. PubMed ID: 17412461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of serologic assays for influenza virus A (H5N1).
    Stephenson I; Heath A; Major D; Newman RW; Hoschler K; Junzi W; Katz JM; Weir JP; Zambon MC; Wood JM
    Emerg Infect Dis; 2009 Aug; 15(8):1252-9. PubMed ID: 19751587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
    Rudenko L; van den Bosch H; Kiseleva I; Mironov A; Naikhin A; Larionova N; Bushmenkov D
    Vaccine; 2011 Jul; 29 Suppl 1():A40-4. PubMed ID: 21684428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis.
    Samuel D; Warrener L; Hoschler K
    J Med Virol; 2011 Apr; 83(4):559-67. PubMed ID: 21328368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study on influenza vaccine clinical trial serology - part 1: CHMP compliance study.
    Wood JM; Newman RW; Daas A; Terao E; Buchheit KH
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):27-35. PubMed ID: 21619854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
    Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
    Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
    Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of influenza serological techniques by international collaborative study.
    Wood JM; Gaines-Das RE; Taylor J; Chakraverty P
    Vaccine; 1994 Feb; 12(2):167-74. PubMed ID: 8147099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
    Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
    Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.
    Waldock J; Zheng L; Remarque EJ; Civet A; Hu B; Jalloh SL; Cox RJ; Ho S; Hoschler K; Ollinger T; Trombetta CM; Engelhardt OG; Caillet C
    mSphere; 2021 Aug; 6(4):e0056721. PubMed ID: 34319129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study.
    Wood JM; Montomoli E; Newman RW; Daas A; Buchheit KH; Terao E
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):36-54. PubMed ID: 21619855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first international standard for antibodies to HPV 16.
    Ferguson M; Wilkinson DE; Heath A; Matejtschuk P
    Vaccine; 2011 Sep; 29(38):6520-6. PubMed ID: 21767589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.